Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-associated ring-CH-type finger protein 7 (MARCHF7) is a membrane-bound E3 ubiquitin ligase enzyme implicated in the addition of ubiquitin to substrate proteins, a process essential for targeting proteins for degradation or for directing them to specific membrane compartments. MARCHF7 modulates processes such as autophagy by ubiquitinating proteins like ATG14, regulates T-cell proliferation, and contributes to the downregulation of inflammasome activity via ubiquitin-mediated degradation. High levels of expression are seen in various tissues, and dysfunction of this protein is associated with diseases of immune regulation and may contribute to cancer and other pathologies
Inhibition or modulation of E3 ubiquitin ligase activity, affecting protein stability and signaling; Modulation of autophagy through ubiquitination of autophagy-related proteins (e.g., ATG14)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-associated ring-CH-type finger protein 7 (MARCHF7).